Supplementary online material

 

Individual papers on specific antibodies ((1-11)). Data from these paper and their supplementary materials were parsed, curated and entered into the bNAber database

 

 

 

1.         Walker, L.M., Huber, M., Doores, K.J., Falkowska, E., Pejchal, R., Julien, J.P., Wang, S.K., Ramos, A., Chan-Hui, P.Y., Moyle, M. et al. (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature, 477, 466-470.

2.         Chuang, G.Y., Acharya, P., Schmidt, S.D., Yang, Y., Louder, M.K., Zhou, T., Kwon, Y.D., Pancera, M., Bailer, R.T., Doria-Rose, N.A. et al. (2013) Residue-Level Prediction of HIV-1 Antibody Epitopes Based on Neutralization of Diverse Viral Strains. Journal of virology.

3.         Huang, J., Ofek, G., Laub, L., Louder, M.K., Doria-Rose, N.A., Longo, N.S., Imamichi, H., Bailer, R.T., Chakrabarti, B., Sharma, S.K. et al. (2012) Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature, 491, 406-412.

4.         Georgiev, I.S., Doria-Rose, N.A., Zhou, T., Kwon, Y.D., Staupe, R.P., Moquin, S., Chuang, G.Y., Louder, M.K., Schmidt, S.D., Altae-Tran, H.R. et al. (2013) Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Science, 340, 751-756.

5.         Scheid, J.F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T.Y., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K. et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science, 333, 1633-1637.

6.         Liao, H.X., Lynch, R., Zhou, T., Gao, F., Alam, S.M., Boyd, S.D., Fire, A.Z., Roskin, K.M., Schramm, C.A., Zhang, Z. et al. (2013) Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature, 496, 469-476.

7.         Wu, X., Yang, Z.Y., Li, Y., Hogerkorp, C.M., Schief, W.R., Seaman, M.S., Zhou, T., Schmidt, S.D., Wu, L., Xu, L. et al. (2010) Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science, 329, 856-861.

8.         Diskin, R., Scheid, J.F., Marcovecchio, P.M., West, A.P., Jr., Klein, F., Gao, H., Gnanapragasam, P.N., Abadir, A., Seaman, M.S., Nussenzweig, M.C. et al. (2011) Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science, 334, 1289-1293.

9.         Andrabi, R., Williams, C., Wang, X.H., Li, L., Choudhary, A.K., Wig, N., Biswas, A., Luthra, K., Nadas, A., Seaman, M.S. et al. (2013) Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals. Virology, 439, 81-88.

10.       Diskin, R., Klein, F., Horwitz, J.A., Halper-Stromberg, A., Sather, D.N., Marcovecchio, P.M., Lee, T., West, A.P., Jr., Gao, H., Seaman, M.S. et al. (2013) Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies. The Journal of experimental medicine, 210, 1235-1249.

11.       Walker, L.M., Phogat, S.K., Chan-Hui, P.Y., Wagner, D., Phung, P., Goss, J.L., Wrin, T., Simek, M.D., Fling, S., Mitcham, J.L. et al. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science, 326, 285-289.